Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Mitochondrial DNA mutations in multiple sclerosis

B Kalman1, F D Lublin, H Alder

  • 1Department of Neurology, Thomas Jefferson University, Philadelphia, PA 19107, USA.

Multiple Sclerosis (Houndmills, Basingstoke, England)
|April 1, 1995
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Correction to: MicroRNA gene expression during retinoic acid-induced differentiation of human acute promyelocytic leukemia.

Oncogene·2022
Same author

Axonal water fraction as marker of white matter injury in primary-progressive multiple sclerosis: a longitudinal study.

European journal of neurology·2019
Same author

Engineering human 3D micromuscles with co-culture of fibroblasts and myoblasts.

Computer methods in biomechanics and biomedical engineering·2015
Same author

The CombiRx trial of combined therapy with interferon and glatiramer acetate in relapsing remitting MS: Design and baseline characteristics.

Multiple sclerosis and related disorders·2015
Same author

Clinical course in multiple sclerosis patients presenting with a history of progressive disease.

Multiple sclerosis and related disorders·2015
Same author

Circulating miRNA markers show promise as new prognosticators for multiple myeloma.

Leukemia·2014
Same journal

Association of epiretinal membranes with disability in people with multiple sclerosis.

Multiple sclerosis (Houndmills, Basingstoke, England)·2026
Same journal

Epiretinal membranes in multiple sclerosis: A window into glial pathobiology?

Multiple sclerosis (Houndmills, Basingstoke, England)·2026
Same journal

Profiling the long-term risk of severe adverse events in a cohort of multiple sclerosis patients treated with different treatment sequences: Results from the Italian Multiple Sclerosis and Related Disorders Registry (I-MS&RD) (ProSA study).

Multiple sclerosis (Houndmills, Basingstoke, England)·2026
Same journal

UK consensus on pregnancy in multiple sclerosis: An update to 'Association of British Neurologists' guidance.

Multiple sclerosis (Houndmills, Basingstoke, England)·2026
Same journal

Comparative effectiveness of rituximab versus ocrelizumab in relapsing multiple sclerosis on clinical relapses and radiological outcomes in British Columbia, Canada.

Multiple sclerosis (Houndmills, Basingstoke, England)·2026
Same journal

Invisible symptoms in multiple sclerosis and their impact on social role participation: A multidimensional analysis.

Multiple sclerosis (Houndmills, Basingstoke, England)·2026
See all related articles

Leber

Area of Science:

  • Genetics
  • Neurology
  • Ophthalmology

Background:

  • Leber's hereditary optic neuropathy (LHON) is linked to specific mitochondrial DNA mutations.
  • Multiple Sclerosis (MS) is a complex neurological disorder with potential genetic components.
  • Investigating shared genetic factors between LHON and MS may reveal disease mechanisms.

Purpose of the Study:

  • To investigate the presence of mitochondrial DNA mutations, particularly those associated with LHON, in patients with Multiple Sclerosis (MS).
  • To determine if specific LHON mutations are more frequent in MS patients compared to controls.
  • To explore potential links between mitochondrial DNA variants and MS predisposition.

Main Methods:

  • Sequencing and restriction endonuclease analysis of mitochondrial DNA.

Related Experiment Videos

  • Comparison of mutation frequencies between randomly selected MS patients and control groups.
  • Correlation analysis between detected mutations and disease severity (visual loss).

    • Main Results:

    • Class I LHON mutations, strongly linked to blindness, were absent in MS patients.
    • A higher frequency of class II LHON mutations (unknown pathogenic significance) was observed in MS patients compared to controls.
    • Simultaneous class II LHON mutations (e.g., at positions 4216, 13,708, 15,257) were significantly more common in MS patients (20.8%) than in controls (9.5%).

    Conclusions:

    • Blindness-causing LHON mutations are not shared with randomly selected MS patients.
    • Certain sets of mitochondrial DNA mutations/variants may be associated with and predispose individuals to MS.
    • Further research is warranted to investigate the role of mitochondrial DNA variants in MS pathogenesis.